Informational profileWatchlist
Eloralintide
An investigational selective amylin receptor agonist.
Also known as LY3841136
What it interacts with
A target relationship describes a research mechanism, not a proven personal outcome.
How far the research has gone
Phase 3 trials ongoing
Developer: Eli Lilly
Status as of: 2026-09-15
Scope: Multinational development
Structure provenance
Conceptual visualization only
We have not added a verified sequence or experimental coordinate set for this record. The orbital graphic represents mapped target systems, not the molecule's physical 3D shape. No synthetic molecular model is presented as measured data.
Compare by target
Nearby signals
This profile is informational. Inclusion does not mean OnimaChain sells this molecule or that a regulator has approved it. Development status can change and should be checked against the linked primary source.